Medicarpin, a potent bioactive compound found in plants like Sophora japonica and Glycyrrhiza species, exhibits diverse medicinal properties. Despite limited natural plant sources and low yields, this study identified eight key genes governing medicarpin biosynthesis. Through genetic engineering in Saccharomyces cerevisiae using liquiritigenin as a substrate, the team achieved medicarpin production at 0.82 ± 0.18 mg/L. Gene copy enhancements of vestitone reductase (VR) and pterocarpan synthase (PTS) boosted yields to 2.05 ± 0.72 mg/L. This research lays a robust foundation for economically viable and sustainable synthetic production of medicarpin via a synthetic biology approach.
Related Posts
Advances in metastatic breast cancer treatments bring hope and improved survival.
Treatments for metastatic breast cancer have played a pivotal role in reducing mortality rates. Advances in targeted therapies, hormone therapies, and immunotherapies have improved the effectiveness of treatments, slowing disease progression and enhancing overall survival. Early detection, personalized treatment plans, and a multidisciplinary approach have also contributed. Patients now benefit from a more comprehensive understanding […]
Journal Impact Factor: All That Matters
The impact factor, often abbreviated as IF, is a measure reflecting the average number of citations that a paper published in a journal receives over a defined period of time. Conceptually developed in the 1960s by Eugene Garfield, founder of the Institute for Scientific Information (ISI), IF is now frequently used as a proxy for […]
Machines vary in cell production speed for cancer treatments.
The speed at which machines can produce cells for cancer treatment depends on various factors, including the specific cell type and quantity required. Advanced bioprocessing technologies and automation have increased production efficiency. In some cases, machines can generate large quantities of cells in a matter of hours, while more complex and specialized processes may take […]